These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 404392)

  • 41. Increasing drug resistance of Mycobacterium tuberculosis isolates in Ontario, Canada, 1987-1998.
    Remis RS; Jamieson F; Chedore P; Haddad A; Vernich L
    Clin Infect Dis; 2000 Aug; 31(2):427-32. PubMed ID: 10987700
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Bactericidal therapy in patients with tuberculosis].
    Krasnov VA; Ursov IG
    Probl Tuberk Bolezn Legk; 2004; (3):21-6. PubMed ID: 15338895
    [No Abstract]   [Full Text] [Related]  

  • 43. Rapid direct detection of multiple rifampin and isoniazid resistance mutations in Mycobacterium tuberculosis in respiratory samples by real-time PCR.
    Marín M; García de Viedma D; Ruíz-Serrano MJ; Bouza E
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4293-300. PubMed ID: 15504855
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of the potential role of a new mutation in mabA in modifying the response of Mycobacterium tuberculosis to isoniazid.
    Alonso M; Martínez-Lirola M; Palacios JJ; Menéndez Á; Herranz M; Martínez S; Bouza E; García-de-Viedma D
    Tuberculosis (Edinb); 2013 Nov; 93(6):664-7. PubMed ID: 23973657
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Molecular characterization of isoniazid resistance in Mycobacterium tuberculosis: identification of a novel mutation in inhA.
    Leung ET; Ho PL; Yuen KY; Woo WL; Lam TH; Kao RY; Seto WH; Yam WC
    Antimicrob Agents Chemother; 2006 Mar; 50(3):1075-8. PubMed ID: 16495272
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [KatG Ser3 15Thr mutation as the main reason of isoniazid resistance in Mycobacterium tuberculosis isolated in the Novosibirsk and Kemerovo Regions].
    Voronina EN; Vikhrova MA; Khrapov EA; Kinsht VN; Norkina OV; Gorbunova EV; Shabaldin AV; Glushkov AN; Krasnov VA; Filipenko ML
    Mol Gen Mikrobiol Virusol; 2004; (3):8-11. PubMed ID: 15354935
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Resistance pattern of Mycobacterium tuberculosis strain H37Rv to a new antibiotic DL 8280].
    Tsukamura M
    Kekkaku; 1984 May; 59(5):337-9. PubMed ID: 6434783
    [No Abstract]   [Full Text] [Related]  

  • 48. Evaluation of Mycobacterium tuberculosis cross-resistance to isoniazid, rifampicin and levofloxacin with their respective structural analogs.
    Imperiale BR; Di Giulio ÁB; Adrián Cataldi A; Morcillo NS
    J Antibiot (Tokyo); 2014 Nov; 67(11):749-54. PubMed ID: 24894185
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The activity of penicillin and penicillin-isoniazid combinations against isoniazid-susceptible and -resistant mycobacterium tuberculosis.
    VAICHULIS EM; VICHER EE; NOVAK MV
    Am Rev Respir Dis; 1962 Nov; 86():744-8. PubMed ID: 13995740
    [No Abstract]   [Full Text] [Related]  

  • 50. A review of the action of isoniazid.
    Youatt J
    Am Rev Respir Dis; 1969 May; 99(5):729-49. PubMed ID: 4306211
    [No Abstract]   [Full Text] [Related]  

  • 51. Isoniazid and the survival of tubercle bacilli in airborne droplet nuclei.
    Loudon RG; Bumgarner LR; Coffman GK
    Am Rev Respir Dis; 1969 Aug; 100(2):172-6. PubMed ID: 4979743
    [No Abstract]   [Full Text] [Related]  

  • 52. Acquired isoniazid resistance and catalase activity of myobacteria.
    Wayne LG; Diaz GA; Doubek JR
    Am Rev Respir Dis; 1968 May; 97(5):909-13. PubMed ID: 4869537
    [No Abstract]   [Full Text] [Related]  

  • 53. An enzyme system of Mycobacterium tuberculosis that reacts specifically with isoniazid. I.
    Youatt J; Tham SH
    Am Rev Respir Dis; 1969 Jul; 100(1):25-30. PubMed ID: 4307733
    [No Abstract]   [Full Text] [Related]  

  • 54. Prelimianry observations on the increase in isoniazid resistance of M. tuberculosis H37RV after exposure to an extract of tuberculous tissue.
    URBANCIK R; TRNKA L
    Am Rev Respir Dis; 1962 Apr; 85():596-8. PubMed ID: 13923896
    [No Abstract]   [Full Text] [Related]  

  • 55. [Comparison of resistance of Mycobacterium tuberculosis in primo- and subcultures].
    KOSTRZENSKI W; PAKLERSKA-POBRATYN H
    Gruzlica (1926); 1956 Jul; 24(7):569-82. PubMed ID: 13375950
    [No Abstract]   [Full Text] [Related]  

  • 56. [Experience with resistance determination in tuberculosis].
    HOFMANN P; NICKEL L
    Beitr Klin Tuberk Spezif Tuberkuloseforsch; 1954; 112(3):191-200. PubMed ID: 13219059
    [No Abstract]   [Full Text] [Related]  

  • 57. BACTERICIDAL EFFECT OF ISONIAZID AS A FUNCTION OF TIME.
    MIDDLEBROOK G
    Am Rev Respir Dis; 1965 May; 91():774-5. PubMed ID: 14280955
    [No Abstract]   [Full Text] [Related]  

  • 58. Bacteria: Assessing resistance to new antibiotics.
    Hochberg ME; Jansen G
    Nature; 2015 Mar; 519(7542):158. PubMed ID: 25762274
    [No Abstract]   [Full Text] [Related]  

  • 59. [The antibacterial action in vivo of a single therapeutic dose of isoniazid in mice infected with Mycobacterium tuberculosis labeled with radiocarbon C-14].
    MAURO B; PASQUIER JF
    Ann Ist Carlo Forlanini; 1960; 20():412-7. PubMed ID: 13768453
    [No Abstract]   [Full Text] [Related]  

  • 60. Antibiotics: An irresistible newcomer.
    Wright G
    Nature; 2015 Jan; 517(7535):442-4. PubMed ID: 25561172
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.